Joshua Teperowski Monrad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joshua Teperowski Monrad has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Gavin Leech
Department of Computer Science, University of Bristol, UK
4 shared publications - Jan Markus Brauner
University of Oxford
4 shared publications - Mrinank Sharma
University of Oxford
4 shared publications - Sören Mindermann
EECS UC Berkeley University of Oxford
4 shared publications - Brian David Earp
Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
3 shared publications - Jan Kulveit
Alignment of Complex Systems Research Group, Center for Theoretical Studies, Charles University
3 shared publications
Latest Publications
- Open Access
- 10 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-3
Author Correction: How social relationships shape moral wrongness judgments
- 10 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-3
Open AccessAuthor Correction: How social relationships shape moral wrongness judgments
- Open Access
- 26 August 2022
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 18 (8) , e1010435
Seasonal variation in SARS-CoV-2 transmission in temperate climates: A Bayesian modelling study in 143 European regions
Although seasonal variation has a known influence on the transmission of several respiratory viral infections, its role in SARS-CoV-2 transmission remains unclear. While there is a sizable and growing literature on environmental drivers of COVID-19 transmission, recent reviews have highlighted conflicting and inconclusive findings. This indeterminacy partly owes to the fact that seasonal variation relates to viral transmission by a complicated web of causal pathways, including many interacting biological and behavioural factors. Since analyses of specific factors cannot determine the aggregate strength of seasonal forcing, we sidestep the challenge of disentangling various possible causal paths in favor of a holistic approach. We model seasonality as a sinusoidal variation in transmission and infer a single Bayesian estimate of the overall seasonal effect. By extending two state-of-the-art models of non-pharmaceutical intervention (NPI) effects and their datasets covering 143 regions in temperate Europe, we are able to adjust our estimates for the role of both NPIs and mobility patterns in reducing transmission. We find strong seasonal patterns, consistent with a reduction in the time-varying reproduction number R(t) (the expected number of new infections generated by an infectious individual at time t) of 42.1% (95% CI: 24.7%—53.4%) from the peak of winter to the peak of summer. These results imply that the seasonality of SARS-CoV-2 transmission is comparable in magnitude to the most effective individual NPIs but less than the combined effect of multiple interventions.
- 26 August 2022
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 18 (8) , e1010435
Open AccessSeasonal variation in SARS-CoV-2 transmission in temperate climates: A Bayesian modelling study in 143 European regions
Although seasonal variation has a known influence on the transmission of several respiratory viral infections, its role in SARS-CoV-2 transmission remains unclear. While there is a sizable and growing literature on environmental drivers of COVID-19 transmission, recent reviews have highlighted conflicting and inconclusive findings. This indeterminacy partly owes to the fact that seasonal variation relates to viral transmission by a complicated web of causal pathways, including many interacting biological and behavioural factors. Since analyses of specific factors cannot determine the aggregate strength of seasonal forcing, we sidestep the challenge of disentangling various possible causal paths in favor of a holistic approach. We model seasonality as a sinusoidal variation in transmission and infer a single Bayesian estimate of the overall seasonal effect. By extending two state-of-the-art models of non-pharmaceutical intervention (NPI) effects and their datasets covering 143 regions in temperate Europe, we are able to adjust our estimates for the role of both NPIs and mobility patterns in reducing transmission. We find strong seasonal patterns, consistent with a reduction in the time-varying reproduction number R(t) (the expected number of new infections generated by an infectious individual at time t) of 42.1% (95% CI: 24.7%—53.4%) from the peak of winter to the peak of summer. These results imply that the seasonality of SARS-CoV-2 transmission is comparable in magnitude to the most effective individual NPIs but less than the combined effect of multiple interventions.
- Open Access
- 26 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1
Author Correction: How social relationships shape moral wrongness judgments
- 26 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1
Open AccessAuthor Correction: How social relationships shape moral wrongness judgments
- Open Access
- 26 October 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (5) , e0186421
Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks
The COVID-19 pandemic has demonstrated the world’s vulnerability to biological catastrophe and elicited unprecedented scientific efforts. Some of this work and its derivatives, however, present dual-use risks (i.e., potential harm from misapplication of beneficial research) that have largely gone unaddressed.
- 26 October 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (5) , e0186421
Open AccessRapid Proliferation of Pandemic Research: Implications for Dual-Use Risks
The COVID-19 pandemic has demonstrated the world’s vulnerability to biological catastrophe and elicited unprecedented scientific efforts. Some of this work and its derivatives, however, present dual-use risks (i.e., potential harm from misapplication of beneficial research) that have largely gone unaddressed.
- Top Cited PapersOpen Access
- 5 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
European governments use non-pharmaceutical interventions (NPIs) to control resurging waves of COVID-19. However, they only have outdated estimates for how effective individual NPIs were in the first wave. We estimate the effectiveness of 17 NPIs in Europe’s second wave from subnational case and death data by introducing a flexible hierarchical Bayesian transmission model and collecting the largest dataset of NPI implementation dates across Europe. Business closures, educational institution closures, and gathering bans reduced transmission, but reduced it less than they did in the first wave. This difference is likely due to organisational safety measures and individual protective behaviours—such as distancing—which made various areas of public life safer and thereby reduced the effect of closing them. Specifically, we find smaller effects for closing educational institutions, suggesting that stringent safety measures made schools safer compared to the first wave. Second-wave estimates outperform previous estimates at predicting transmission in Europe’s third wave.
- 5 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Top Cited PapersOpen AccessUnderstanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
European governments use non-pharmaceutical interventions (NPIs) to control resurging waves of COVID-19. However, they only have outdated estimates for how effective individual NPIs were in the first wave. We estimate the effectiveness of 17 NPIs in Europe’s second wave from subnational case and death data by introducing a flexible hierarchical Bayesian transmission model and collecting the largest dataset of NPI implementation dates across Europe. Business closures, educational institution closures, and gathering bans reduced transmission, but reduced it less than they did in the first wave. This difference is likely due to organisational safety measures and individual protective behaviours—such as distancing—which made various areas of public life safer and thereby reduced the effect of closing them. Specifically, we find smaller effects for closing educational institutions, suggesting that stringent safety measures made schools safer compared to the first wave. Second-wave estimates outperform previous estimates at predicting transmission in Europe’s third wave.
- Open Access
- 1 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
How social relationships shape moral wrongness judgments
Judgments of whether an action is morally wrong depend on who is involved and the nature of their relationship. But how, when, and why social relationships shape moral judgments is not well understood. We provide evidence to address these questions, measuring cooperative expectations and moral wrongness judgments in the context of common social relationships such as romantic partners, housemates, and siblings. In a pre-registered study of 423 U.S. participants nationally representative for age, race, and gender, we show that people normatively expect different relationships to serve cooperative functions of care, hierarchy, reciprocity, and mating to varying degrees. In a second pre-registered study of 1,320 U.S. participants, these relationship-specific cooperative expectations (i.e., relational norms) enable highly precise out-of-sample predictions about the perceived moral wrongness of actions in the context of particular relationships. In this work, we show that this ‘relational norms’ model better predicts patterns of moral wrongness judgments across relationships than alternative models based on genetic relatedness, social closeness, or interdependence, demonstrating how the perceived morality of actions depends not only on the actions themselves, but also on the relational context in which those actions occur.
- 1 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Open AccessHow social relationships shape moral wrongness judgments
Judgments of whether an action is morally wrong depend on who is involved and the nature of their relationship. But how, when, and why social relationships shape moral judgments is not well understood. We provide evidence to address these questions, measuring cooperative expectations and moral wrongness judgments in the context of common social relationships such as romantic partners, housemates, and siblings. In a pre-registered study of 423 U.S. participants nationally representative for age, race, and gender, we show that people normatively expect different relationships to serve cooperative functions of care, hierarchy, reciprocity, and mating to varying degrees. In a second pre-registered study of 1,320 U.S. participants, these relationship-specific cooperative expectations (i.e., relational norms) enable highly precise out-of-sample predictions about the perceived moral wrongness of actions in the context of particular relationships. In this work, we show that this ‘relational norms’ model better predicts patterns of moral wrongness judgments across relationships than alternative models based on genetic relatedness, social closeness, or interdependence, demonstrating how the perceived morality of actions depends not only on the actions themselves, but also on the relational context in which those actions occur.
- Open Access
Seasonal variation in SARS-CoV-2 transmission in temperate climates
While seasonal variation has a known influence on the transmission of several respiratory viral infections, its role in SARS-CoV-2 transmission remains unclear. As previous analyses have not accounted for the implementation of non-pharmaceutical interventions (NPIs) in the first year of the pandemic, they may yield biased estimates of seasonal effects. Building on two state-of-the-art observational models and datasets, we adapt a fully Bayesian method for estimating the association between seasonality and transmission in 143 temperate European regions. We find strong seasonal patterns, consistent with a reduction in the time-variable R t of 42.1% (95% CI: 24.7% – 53.4%) from the peak of winter to the peak of summer. These results imply that the seasonality of SARS-CoV-2 transmission is comparable in magnitude to the most effective individual NPIs but less than the combined effect of multiple interventions.
Open AccessSeasonal variation in SARS-CoV-2 transmission in temperate climates
While seasonal variation has a known influence on the transmission of several respiratory viral infections, its role in SARS-CoV-2 transmission remains unclear. As previous analyses have not accounted for the implementation of non-pharmaceutical interventions (NPIs) in the first year of the pandemic, they may yield biased estimates of seasonal effects. Building on two state-of-the-art observational models and datasets, we adapt a fully Bayesian method for estimating the association between seasonality and transmission in 143 temperate European regions. We find strong seasonal patterns, consistent with a reduction in the time-variable R t of 42.1% (95% CI: 24.7% – 53.4%) from the peak of winter to the peak of summer. These results imply that the seasonality of SARS-CoV-2 transmission is comparable in magnitude to the most effective individual NPIs but less than the combined effect of multiple interventions.
- Top Cited PapersOpen Access
- 19 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6531) , 802-+
Inferring the effectiveness of government interventions against COVID-19
How to hold down transmission: Early in 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission was curbed in many countries by imposing combinations of nonpharmaceutical interventions. Sufficient data on transmission have now accumulated to discern the effectiveness of individual interventions. Brauner et al. amassed and curated data from 41 countries as input to a model to identify the individual nonpharmaceutical interventions that were the most effective at curtailing transmission during the early pandemic. Limiting gatherings to fewer than 10 people, closing high-exposure businesses, and closing schools and universities were each more effective than stay-at-home orders, which were of modest effect in slowing transmission. Science , this issue p. eabd9338
- 19 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6531) , 802-+
Top Cited PapersOpen AccessInferring the effectiveness of government interventions against COVID-19
How to hold down transmission: Early in 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission was curbed in many countries by imposing combinations of nonpharmaceutical interventions. Sufficient data on transmission have now accumulated to discern the effectiveness of individual interventions. Brauner et al. amassed and curated data from 41 countries as input to a model to identify the individual nonpharmaceutical interventions that were the most effective at curtailing transmission during the early pandemic. Limiting gatherings to fewer than 10 people, closing high-exposure businesses, and closing schools and universities were each more effective than stay-at-home orders, which were of modest effect in slowing transmission. Science , this issue p. eabd9338
- Open Access
- 11 February 2021
- Published by Springer Nature in npj Vaccines
- Vol. 6 (1) , 1-7
Promoting versatile vaccine development for emerging pandemics
The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile development of emergency medical countermeasures such as vaccines. We discuss the role of platform vaccines and prototype pathogen research in modern vaccine development, and outline how previous pathogen-specific funding approaches can be improved to adequately promote vaccine R&D for emerging pandemics. We present a more comprehensive approach to financing vaccine R&D, which maximises biomedical pandemic preparedness by promoting flexible vaccine platforms and translatable research into prototype pathogens. As the numerous platform-based SARS-CoV-2 vaccines show, funders can accelerate pandemic vaccine development by proactively investing in versatile platform technologies. For certain emerging infectious diseases, where vaccine research can translate to other related pathogens with pandemic potential, investment decisions should reflect the full social value of increasing overall preparedness, rather than just the value of bringing a vaccine to market for individual pathogens.
- 11 February 2021
- Published by Springer Nature in npj Vaccines
- Vol. 6 (1) , 1-7
Open AccessPromoting versatile vaccine development for emerging pandemics
The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile development of emergency medical countermeasures such as vaccines. We discuss the role of platform vaccines and prototype pathogen research in modern vaccine development, and outline how previous pathogen-specific funding approaches can be improved to adequately promote vaccine R&D for emerging pandemics. We present a more comprehensive approach to financing vaccine R&D, which maximises biomedical pandemic preparedness by promoting flexible vaccine platforms and translatable research into prototype pathogens. As the numerous platform-based SARS-CoV-2 vaccines show, funders can accelerate pandemic vaccine development by proactively investing in versatile platform technologies. For certain emerging infectious diseases, where vaccine research can translate to other related pathogens with pandemic potential, investment decisions should reflect the full social value of increasing overall preparedness, rather than just the value of bringing a vaccine to market for individual pathogens.